PALO ALTO, Calif., June 28 /PRNewswire-FirstCall/ -- Frost & Sullivan recently named Cardiopulmonary Corp. as the recipient of the 2006 Global Excellence of the Year Award in centralized patient monitoring technology in recognition of the company’s cutting-edge safety applications and continued developments in centralized monitoring.
Remarkable for a company of its size, Cardiopulmonary developed central monitoring solutions, despite not having bedside devices, while maintaining tight focus on the central station, data stream management, and alarm notification.
“Cardiopulmonary believes patient monitoring is intimately linked to the future of the central station,” said Frost & Sullivan research manager Antonio Garcia. “The company has focused on creating easily scalable solutions by being able to interface with any vendor device, while placing a premium on flexibility, which is crucial for modern hospitals.”
The company is in tune with the crucial paradigm shift from legacy patient monitoring systems to best-in-class devices that has taken place due to the convergence of ventilation monitoring, infusion pump monitoring, and core patient monitoring. Cardiopulmonary continues to demonstrate its dedication to innovation in information technologies. As patient safety concerns are driving cooperation, Cardiopulmonary is well poised to take advantage of these new trends.
Cardiopulmonary’s Bernoulli(R) is a sound step for patient safety. It monitors ventilation and sounds an alarm if the ventilation fails. This will provide Cardiopulmonary with a launch pad into infusion pump monitoring as well as specialty and niche applications such as standalone pulse oximetry. Few companies can deliver such critical levels of service and quality reliably.
“Cardiopulmonary is not just an integration company. It can work with other integration companies and can also provide its own best-in-class integration services,” noted Garcia. “In both cases, Cardiopulmonary has the in-house expertise needed to meet customer needs.”
Frost & Sullivan presents this Award to a company that has demonstrated global excellence in a given business function such as sales, marketing, customer service, technology innovation, product quality, supply chain management, and growth strategy. The Award recipient has distinguished itself through its proactive global integration strategies that can position the company to emerge as a global leader.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About Cardiopulmonary Corp.
Cardiopulmonary Corp. designs, develops, and implements medical software for use in monitoring and mission-critical decision support in a wide range of acute care applications. Based in Connecticut, Cardiopulmonary Corp. is a market leader of IT-centric solutions used in the real-time management and surveillance of critically-ill patients. Cardiopulmonary’s enterprise medical software is used throughout leading hospitals in the U.S. For more information, visit http://www.cardiopulmonarycorp.com.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company’s industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.awards.frost.com or http://patientmonitoring.frost.com.
Contact: Stacie Jones 210.247.2450 Stacie.jones@frost.com
Frost & Sullivan
CONTACT: Stacie Jones of Frost & Sullivan, +1-210-247-2450, orStacie.jones@frost.com
